www.hhs.gov U.S. Department of Health and Human Services
Activity Outline
CDER Small Business and Industry Assistance (SBIA) Webinar: Financial Incentives for CDER Medical Products
June 10, 2019
Live Webinar
Activity Coordinator
Lisa Misevicz
lisa.misevicz@fda.hhs.gov
 
Description

Attendees will be able to identify and distinguish which FDA CDER financial incentive programs apply to different stakeholders. PDUFA waivers, small business waivers, refunds, BsUFA waivers, and Orphan Drug programs will be reviewed by subject matter experts.


References
  • FDA Webpage: Economic Assistance and Incentives for Drug Development https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/economic-assistance-and-incen tives-drug-development
Learning Objectives
  • Demonstrate how to apply the FDA economic assistance and incentives for drug development for different types of drug applications.
Target Audience
This activity is intended for physicians, pharmacists, and nurses.
Agenda
Day 1 June 10, 2019
TimeTopicSpeaker
10:00 - 10:05 AM SBIA Webinar Overview Forest Ford
10:05 - 11:05 AM PDUFA Financial Incentives Jeen Min
11:05 - 11:25 AM BsUFA/GDUFA Financial Incentives Beena Alex, MPH, MBA
11:25 - 11:35 AM Break
11:35 - 11:55 AM Panel Discussion Jeen Min
Beena Alex, MPH, MBA
11:55 - 12:25 PM Lunch
12:25 - 1:10 PM Orphan Drug Financial Incentives Roberta Szydlo, RPh, MBA
1:10 - 1:55 PM Exclusivity Financial Incentives Rinku Patel
1:55 - 2:25 PM PRV Financial Incentives PETER CHEN
2:25 - 2:35 PM Break
2:35 - 2:55 PM Panel Discussion Roberta Szydlo, RPh, MBA
Rinku Patel
PETER CHEN
2:55 - 3:00 PM SBIA Closing Forest Ford
Continuing Education Accreditation
Jointly Accredited Provider
In support of improving patient care, FDA Center for Drug Evaluation and Research is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ICPE Credit
This activity was planned by and for the healthcare team, and learners will receive 4.00 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.
CME
FDA Center for Drug Evaluation and Research designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE
This knowledge-based activity has been assigned ACPE Universal Activity Number JA0002895-0000-19-051-L04-P for 4.00 contact hour(s).
CNE
FDA Center for Drug Evaluation and Research designates this activity for 4.00 contact hour(s).
Requirements for Receiving CE Credit

Physicians, pharmacists, nurses, and those claiming non-physician CME: participants must attest to their attendance and complete the final activity evaluation via the CE Portal (ceportal.fda.gov). For multi-day activities, participants must attest to their attendance and complete the faculty evaluation each day. Final activity evaluations must be completed within two weeks after the activity - no exceptions.

Pharmacists will need their NABP e-profile ID number as well as their DOB in MMDD format in order to claim CE credit.

Important Note regarding completion of evaluations and receiving credit
Attendees have 14 days from the last day of the activity to log in, complete the required evaluation(s) and attest to your attendance to claim credit.Physicians and nurses may then view/print statement of credit. Pharmacists should log into the CPE monitor 10 weeks after the last session of the activity to obtain their CE credit.
Disclosure

Faculty
  • Alex, Beena, MPH, MBA, Lead Management Analyst, Food and Drug Administration - nothing to disclose
  • CHEN, PETER, Pharmacist, FDA - nothing to disclose
  • Ford, Forest, CSO, FDA - nothing to disclose
  • Min, Jeen, Branch Cheif, FDA - nothing to disclose
  • Patel, Rinku, Pharmacist, CDER - nothing to disclose
  • Szydlo, Roberta, RPh, MBA, Health Science Administrator, Food and Drug Administration - nothing to disclose

Planning Committee
  • Giroux, Virginia, MSN, FNP-BC, Associate Director for Accreditation, FDA/CDER/OEP/DLOD - nothing to disclose
  • Kleppinger, Cynthia, MD, Medical Officer, FDA - nothing to disclose
  • Stodart, Brenda, PharmD, BCGP, Program Director, FDA - nothing to disclose

CE Consultation and Accreditation Team
  • Lisa Thompson, MSHA, MBA, CE Consultant, FDA/CDER/OEP/DLOD - nothing to disclose
  • Giroux, Virginia, MSN, FNP-BC, Associate Director for Accreditation, FDA/CDER/OEP/DLOD - nothing to disclose
  • Zawalick, Karen, CE Team Leader, FDA/CDER/OEP/DLOD - nothing to disclose
Registration Fee and Refunds
Registration is complimentary, therefore refunds are not applicable.
Requirements for Certificate of Completion (Non CE)
Must attend 90% of the activity.
ACCME Joint Accreditation
  • This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
  • This system is provided for Government-authorized use only.
  • Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
  • Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
  • By using this system, you understand and consent to the following:
    • The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
    • Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.